Glenmark pharmaceuticals have introduced the antiviral drug Favipiravir under the brand name FabiFlu to treat patients with mild to moderate Covid-19. The company gave this information on Saturday. According to the Health Ministry, a record of 14 thousand 516 cases of coronavirus was reported in the country on Saturday. Now the number of people infected with this epidemic in the country has increased to 3 lakh 95 thousand 48. This epidemic has killed 12 thousand 948 people so far.
The Mumbai-based company said on Friday that it had received permission from the Drug Controller General of India (DGCI) to manufacture and market the drug. The company said that febiflu is a drug approved for the treatment of coronavirus, favipiravir.
Glenmark Pharmaceuticals chairman and managing director Glenn Saldanha said, "This approval has come at a time when coronavirus cases in India are increasing more rapidly than before." This has put our healthcare system under a lot of pressure. ”He hoped that the availability of effective treatment like Fabiflu would help reduce this pressure to a great extent.
Saldanha said that in clinical trials Fabiflu showed fairly good results on patients suffering from a mild infection of the coronavirus. He added that in addition to this it is a food drug that is a convenient treatment option.
He said that the company will work closely with the government and the medical community to make this drug easily available to patients across the country. This medicine will be available at the price of Rs 103 per tablet on the advice of a doctor. He said that two doses of 1800 Mg would have to be taken on the first day. After that, two doses of 800 mg have to be taken for 14 days. Glenmark Pharma said that patients with minor infections who are suffering from diabetes or heart disease can also be given this medicine.
Earlier, the Drug Controller General of India (DCGI) allowed domestic company Glenmark Pharmaceuticals to manufacture and sell 'favipiravir' pill (200 mg) as part of the expeditious permitting process, considering the emergency and medical requirement required for covid-19.
Rajasthan Tourism App - Welcomes to the land of Sun, Sand and adventures